# Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.

> **NCT03398356** · PHASE4 · COMPLETED · sponsor: **Wroclaw Medical University** · enrollment: 47 (actual)

## Conditions studied

- PreDiabetes
- Impaired Fasting Glucose (IFG)
- Impaired Glucose Tolerance (IGT)

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03398356
- **Lead sponsor:** Wroclaw Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-20
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03398356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03398356, "Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03398356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*